Purchases and Sales Made in Q3 2022 in Sangamo Therapeutics, Inc (SGMO)
This table provides information about the institutional ownership of Sangamo Therapeutics, Inc (SGMO) during Q3 2022. The information is specifically focused on institutions that hold shares of SANGAMO THERAPEUTICS, INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 15, 2022
Q3 2022
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-288K- 65.41% |
$1.23M - $1.84M
|
152K
$178K
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-320K- 22.64% |
$1.37M - $2.05M
|
1.09M
$1.28M
|
|
Nov 14, 2022
Q3 2022
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-396K- 54.24% |
$1.69M - $2.53M
|
334K
$391K
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-581K- 48.17% |
$2.48M - $3.71M
|
625K
$731K
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-771K- 9.96% |
$3.29M - $4.93M
|
6.97M
$8.15M
|